298 related articles for article (PubMed ID: 22359603)
1. The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.
Chand AL; Wijayakumara DD; Knower KC; Herridge KA; Howard TL; Lazarus KA; Clyne CD
PLoS One; 2012; 7(2):e31593. PubMed ID: 22359603
[TBL] [Abstract][Full Text] [Related]
2. Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells.
Lai CF; Flach KD; Alexi X; Fox SP; Ottaviani S; Thiruchelvam PT; Kyle FJ; Thomas RS; Launchbury R; Hua H; Callaghan HB; Carroll JS; Charles Coombes R; Zwart W; Buluwela L; Ali S
Nucleic Acids Res; 2013 Dec; 41(22):10228-40. PubMed ID: 24049078
[TBL] [Abstract][Full Text] [Related]
3. The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer-promoter interactions.
Tong Z; Liu Y; Yu X; Martinez JD; Xu J
J Biol Chem; 2019 Dec; 294(51):19667-19682. PubMed ID: 31744881
[TBL] [Abstract][Full Text] [Related]
4. LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression.
Bianco S; Jangal M; Garneau D; Gévry N
Oncogene; 2015 Aug; 34(34):4509-18. PubMed ID: 25435372
[TBL] [Abstract][Full Text] [Related]
5. The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene.
Annicotte JS; Chavey C; Servant N; Teyssier J; Bardin A; Licznar A; Badia E; Pujol P; Vignon F; Maudelonde T; Lazennec G; Cavailles V; Fajas L
Oncogene; 2005 Dec; 24(55):8167-75. PubMed ID: 16091743
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
8. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.
Millour J; Constantinidou D; Stavropoulou AV; Wilson MS; Myatt SS; Kwok JM; Sivanandan K; Coombes RC; Medema RH; Hartman J; Lykkesfeldt AE; Lam EW
Oncogene; 2010 May; 29(20):2983-95. PubMed ID: 20208560
[TBL] [Abstract][Full Text] [Related]
9. The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion.
Chand AL; Herridge KA; Thompson EW; Clyne CD
Endocr Relat Cancer; 2010 Dec; 17(4):965-75. PubMed ID: 20817789
[TBL] [Abstract][Full Text] [Related]
10. GREB1 isoforms regulate proliferation independent of ERα co-regulator activities in breast cancer.
Haines CN; Braunreiter KM; Mo XM; Burd CJ
Endocr Relat Cancer; 2018 Jul; 25(7):735-746. PubMed ID: 29695586
[TBL] [Abstract][Full Text] [Related]
11. LRH-1 governs vital transcriptional programs in endocrine-sensitive and -resistant breast cancer cells.
Bianco S; Brunelle M; Jangal M; Magnani L; Gévry N
Cancer Res; 2014 Apr; 74(7):2015-25. PubMed ID: 24520076
[TBL] [Abstract][Full Text] [Related]
12. The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells.
Thiruchelvam PT; Lai CF; Hua H; Thomas RS; Hurtado A; Hudson W; Bayly AR; Kyle FJ; Periyasamy M; Photiou A; Spivey AC; Ortlund EA; Whitby RJ; Carroll JS; Coombes RC; Buluwela L; Ali S
Breast Cancer Res Treat; 2011 Jun; 127(2):385-96. PubMed ID: 20607599
[TBL] [Abstract][Full Text] [Related]
13. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
[TBL] [Abstract][Full Text] [Related]
15. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
Laganière J; Deblois G; Giguère V
Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ERα-GREB1 Transcriptional Axis.
Wu Y; Zhang Z; Cenciarini ME; Proietti CJ; Amasino M; Hong T; Yang M; Liao Y; Chiang HC; Kaklamani VG; Jeselsohn R; Vadlamudi RK; Huang TH; Li R; De Angelis C; Fu X; Elizalde PV; Schiff R; Brown M; Xu K
Cancer Res; 2018 Feb; 78(3):671-684. PubMed ID: 29212856
[TBL] [Abstract][Full Text] [Related]
18. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
19. Oestradiol reduces liver receptor homolog-1 mRNA transcript stability in breast cancer cell lines.
Lazarus KA; Zhao Z; Knower KC; To SQ; Chand AL; Clyne CD
Biochem Biophys Res Commun; 2013 Aug; 438(3):533-9. PubMed ID: 23911789
[TBL] [Abstract][Full Text] [Related]
20. Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.
Schultz DJ; Wickramasinghe NS; Ivanova MM; Isaacs SM; Dougherty SM; Imbert-Fernandez Y; Cunningham AR; Chen C; Klinge CM
Mol Cancer Ther; 2010 Mar; 9(3):594-605. PubMed ID: 20197399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
